Progressive muscular atrophy variant of familial amyotrophic lateral sclerosis (PMA/ALS)

Journal of the Neurological Sciences

Volumn 177, Issue 2, 2000, Pages 124-130

  Cervenakova, Larisa ^a,b   Protas, Iosif I ^c   Hirano, Asao ^d   Votiakov, Veniamin I ^c   Nedzved, Mikhail K ^c   Kolomiets, Natalia D ^c   Taller, Inna ^a   Park, Kye Yoon ^a   Sambuughin, Nyamkhishig ^e   Gajdusek, D Carleton ^f   Brown, Paul ^a   Goldfarb, Lev G ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b HOLLAND LABORATORY   (United States)

^c Research Institute for Epidemiology & Microbiology RIEM   (Belarus)

^d MONTEFIORE MEDICAL CENTER   (United States)

^e BARROW NEUROLOGICAL INSTITUTE   (United States)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Belarus; D101N mutation; Familial amyotrophic lateral sclerosis; SOD1 gene

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; DISEASE ASSOCIATION; GENE EXPRESSION; GENE MUTATION; HUMAN; MOTONEURON; MUSCLE ATROPHY; NEUROPATHOLOGY; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; BYELARUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCULAR ATROPHY, SPINAL; PEDIGREE; PHENOTYPE; RURAL POPULATION; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 19244377528     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00350-6     Document Type: Article

References (30)

1. Mortara P., Chio A., Rosso M.G., et al. Motor neuron disease in the province of Turin, Italy, 1966-1980: survival analysis in an unselected population. J Neurol Sci. 66:1984;165-173.
2. Brownell B., Oppenheimer D.R., Hughes J. Central nervous system in motor neuron disease. J Neurol Neurosurg Psychiat. 33:1970;338-357.
3. Strong M.J., Hudson A.J., Alvord W.G. Familial amyotrophic lateral sclerosis, 1850-1989: statistical analysis of the world literature. Can J Neurol Sci. 18:1991;45-58.
4. Veltema A.N., Roos R.A.C., Bruyn G.W. Autosomal dominant adult amyotrophic lateral sclerosis: a six generation Dutch family. J Neurol Sci. 97:1990;93-115.
5. Horton W.A., Eldridge R., Brody J.A. Familial motor neuron disease: evidence for at least three different types. Neurology. 26:1976;460-465.
6. Kondo K. Epidemiology of motor disease. Leigh P.N., Swash M. Motor neuron disease. Biology and management. 1995;19-33 Springer-Verlag, Berlin.
7. Tundan R. Disorders of the upper and lower motor neurons. Bradley W.G., Daroff R.B., Fenichel G.M., Marsden C.D. 2nd ed Neurology in clinical practice. 2:1995;1823-1852.
8. Siddique T., Figlewicz D.A., Pericak-Vance M.A., et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. New Engl J Med. 324:1991;1381-1384.
9. Rosen D.R., Siddique T., Patterson D., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
10. Deng H.-X., Hentati A., Tainer J.A., et al. Amyotrophic lateral sclerosis and structural defects in Cu/Zn superoxide dismutase. Science. 261:1993;1047-1051.
11. Shaw C.E., Enayat Z.E., Chioza B.A., et al. Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol. 43:1998;390-394.
12. Cudkowicz M.E., McKenna-Yasek D., Sapp P.E., et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol. 41:1997;210-221.
13. Orrell R.W., Habgood J.J., Gardiner I., et al. Clinical and functional investigation of ten missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology. 48:1997;746-751.
14. Hirano A. Neuropathology of familial amyotrophic lateral sclerosis patients with superoxide dismutase 1 gene mutation. Neuropathology. 18:1998;363-369.
15. Yulug I.G., Katsanis N., de Belleroche J., et al. An improved protocol for the analysis of SOD1 gene mutations, and a new mutation in exon 4. Hum Mol Genet. 4:1995;1101-1104.
16. Lefebvre S., Burglen L., Reboullet S., et al. Identification and characterization of the spinal muscular atrophy determining gene. Cell. 80:1995;155-165.
17. World Federation of Neurology Research Group on Neuromuscular Diseases. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(Suppl.):96-107.
18. Camu W., Billiard M. Coexistence of amyotrophic lateral sclerosis and Werdnig-Hoffman disease within a family. J Neurol Sci. 124:(Suppl.):1994;88-89.
19. Jones C.T., Shaw P.J., Chari G., Brock D.J.H. Identification of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient. Mol Cell Probes. 8:1994;329-330.
20. Orrell R.W., Hadgood J., Rudge P., et al. Difficulties in distinguishing sporadic from familial amyotrophic lateral sclerosis. Ann Neurol. 39:1996;810-812.
21. Ince P.G., Shaw P.J., Slade J.Y., Jones C., Hudgson P. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol. 92:1996;395-403.
22. Ikeda M., Abe K., Aoki M., et al. Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the Cu/Zn superoxide dismutase gene. Neurology. 45:1995;2038-2042.
23. Ince P.G., Lowe J., Shaw P.J. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol. 24:1998;104-117.
24. Cudkowicz M.E., McKenna-Yasek D., Chen C., et al. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann Neurol. 43:1998;703-710.
25. Shibata N., Hirano A., Kobayashi M., et al. Immunocytochemical demonstration of Cu/Zn superoxide dismutase in the spinal cord of patients with familial amyotrophic lateral sclerosis. Acta Histochem Cytochem. 26:1993;619-622.
26. Shibata N., Hirano A., Kobayashi M., et al. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropath Exp Neurol. 55:1996;481-490.
27. Shaw C.E., Enayat Z.E., Powell J.F., et al. Familial amyotrophic lateral sclerosis: molecular pathology of a patient with a SOD1 mutation. Neurology. 49:1997;1612-1616.
28. Hirano A., Kurland L.T., Sayre G.P. Familial amyotrophic lateral sclerosis. Arch Neurol. 16:1967;232-243.
29. Brooks B.R. Introduction: defining optimal management in ALS: from first symptoms to announcement. Neurology. 53:(Suppl 5):1999;S1-S3.
30. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis - a Consensus Conference held at Airlie House, Warrenton, V.A., April 2-4, 1998. Website: [http://www.wfnals.org/Articles/elescorial1998.htm].